Medicus Pharma Provides Interpretation of Positive Phase 2 SkinJect™ DatasetUnusual WhalesMar 9, 2026 at 11:32 AMThe company announced a clinical clearance rate of 73% in the cohort receiving 200 µg at Day 57.
